NEW YORK, NY / ACCESSWIRE / December 24, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Wanda Sports Group Company Limited (WSG)
Class Period: Wanda Sports' securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Wanda Sports' July 26, 2019 initial public offering.
Lead Plaintiff Deadline: January 17, 2020
Throughout the class period, Wanda Sports Group Company Limited allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the lack of major sporting events for its Digital, Production, Sports Solutions ("DPSS") and Spectator Sports segments for its second quarter of 2019, ending before the initial public offering, would negatively impact revenue for the second quarter of 2019; (2) Wanda Sports had suffered a year-over-year decrease in revenue in its second quarter ended June 30, 2019 and would for its fiscal year 2019, primarily related to lower reimbursement revenues accounted for in its DPSS segment and lack of Spectator Sport segment offsets; and (3) as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Learn about your recoverable losses in WSG: http://www.kleinstocklaw.com/pslra-1/wanda-sports-group-company-limited-loss-submission-form?id=5040&from=1
Merit Medical Systems, Inc. (MMSI)
Class Period: February 26, 2019 to October 30, 2019
Lead Plaintiff Deadline: February 3, 2020
The complaint alleges Merit Medical Systems, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) the integrations of acquired companies Cianna Medical, Inc. and Vascular Insights, LLC, including their products, sales people, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule; (b) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during FY19; and (c) in light of the foregoing, the Company’s reported financial guidance for FY19 and FY20 was made without a reasonable basis.
Learn about your recoverable losses in MMSI: http://www.kleinstocklaw.com/pslra-1/merit-medical-systems-inc-loss-submission-form?id=5040&from=1
HEXO Corp. (HEXO)
Class Period: January 25, 2019 to November 15, 2019
Lead Plaintiff Deadline: January 27, 2020
HEXO Corp. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) HEXO’s reported inventory was misstated as the Company was failing to write down or write off obsolete product that no longer had value; (2) HEXO was engaging in channel-stuffing in order to inflate its revenue figures and meet or exceed revenue guidance provided to investors; (3) HEXO was cultivating cannabis at its facility in Niagara, Ontario that was not appropriately licensed by Health Canada; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Learn about your recoverable losses in HEXO: http://www.kleinstocklaw.com/pslra-1/hexo-corp-loss-submission-form?id=5040&from=1
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: The Klein Law Firm
View source version on accesswire.com: